Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $4.1 Million - $5.34 Million
104,066 Added 11.48%
1,010,863 $41.2 Million
Q4 2022

Jan 27, 2023

SELL
$41.75 - $54.5 $1.65 Million - $2.15 Million
-39,504 Reduced 4.17%
906,797 $0
Q3 2022

Nov 01, 2022

SELL
$43.76 - $53.42 $7.18 Million - $8.77 Million
-164,124 Reduced 14.78%
946,301 $41.6 Million
Q2 2022

Aug 25, 2022

SELL
$46.53 - $55.17 $5.7 Million - $6.75 Million
-122,423 Reduced 9.93%
1,110,425 $57.7 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $4.58 Million - $5.67 Million
100,066 Added 8.83%
1,232,848 $64.1 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $21.4 Million - $31.7 Million
-518,169 Reduced 31.39%
1,132,782 $66.8 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $3.17 Million - $4.07 Million
80,804 Added 5.15%
1,650,951 $71 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $17.1 Million - $19.3 Million
475,162 Added 43.39%
1,570,147 $61.2 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $1.13 Million - $1.28 Million
-33,831 Reduced 3.0%
1,094,985 $39.4 Million
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $7.22 Million - $9.19 Million
-215,826 Reduced 16.05%
1,128,816 $41.8 Million
Q3 2020

Oct 26, 2020

SELL
$31.75 - $37.25 $3.16 Million - $3.7 Million
-99,434 Reduced 6.89%
1,344,642 $49.8 Million
Q2 2020

Jul 22, 2020

BUY
$30.12 - $36.54 $4.49 Million - $5.45 Million
149,167 Added 11.52%
1,444,076 $47.7 Million
Q1 2020

Apr 09, 2020

SELL
$27.03 - $38.62 $2.66 Million - $3.8 Million
-98,334 Reduced 7.06%
1,294,909 $42.7 Million
Q4 2019

Jan 28, 2020

BUY
$32.92 - $37.36 $45.9 Million - $52.1 Million
1,393,243 New
1,393,243 $54.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.